Titan Pharmaceuticals Performance
| TTNPDelisted Stock | USD 4.61 0.00 0.00% |
The entity has a beta of -0.38, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Titan Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Titan Pharmaceuticals is likely to outperform the market. Titan Pharmaceuticals right now has a risk of 0.0%. Please validate Titan Pharmaceuticals sortino ratio, semi variance, as well as the relationship between the Semi Variance and day typical price , to decide if Titan Pharmaceuticals will be following its existing price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Titan Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Titan Pharmaceuticals is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Begin Period Cash Flow | 6.8 M | |
| Free Cash Flow | -3.9 M |
Titan |
Titan Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 461.00 in Titan Pharmaceuticals on November 20, 2025 and sell it today you would earn a total of 0.00 from holding Titan Pharmaceuticals or generate 0.0% return on investment over 90 days. Titan Pharmaceuticals is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Titan, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Titan Pharmaceuticals Target Price Odds to finish over Current Price
The tendency of Titan Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 4.61 | 90 days | 4.61 | about 28.93 |
Based on a normal probability distribution, the odds of Titan Pharmaceuticals to move above the current price in 90 days from now is about 28.93 (This Titan Pharmaceuticals probability density function shows the probability of Titan Stock to fall within a particular range of prices over 90 days) .
Titan Pharmaceuticals Price Density |
| Price |
Predictive Modules for Titan Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Titan Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Titan Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Titan Pharmaceuticals is not an exception. The market had few large corrections towards the Titan Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Titan Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Titan Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.28 | |
β | Beta against Dow Jones | -0.38 | |
σ | Overall volatility | 0.36 | |
Ir | Information ratio | 0.04 |
Titan Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Titan Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Titan Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Titan Pharmaceuticals is not yet fully synchronised with the market data | |
| Titan Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (4.71 M) with loss before overhead, payroll, taxes, and interest of (4.37 M). | |
| Titan Pharmaceuticals currently holds about 6.42 M in cash with (3.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44. |
Titan Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Titan Stock often depends not only on the future outlook of the current and potential Titan Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Titan Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 899 K | |
| Cash And Short Term Investments | 2.8 M |
Titan Pharmaceuticals Fundamentals Growth
Titan Stock prices reflect investors' perceptions of the future prospects and financial health of Titan Pharmaceuticals, and Titan Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Titan Stock performance.
| Return On Equity | -0.83 | |||
| Return On Asset | -0.44 | |||
| Current Valuation | 7.38 K | |||
| Shares Outstanding | 1.33 M | |||
| Price To Earning | (3.60) X | |||
| Price To Book | 2.20 X | |||
| Price To Sales | 3,440 X | |||
| EBITDA | (4.7 M) | |||
| Cash And Equivalents | 6.42 M | |||
| Cash Per Share | 0.44 X | |||
| Total Debt | 483 K | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | 2.10 X | |||
| Cash Flow From Operations | (3.88 M) | |||
| Earnings Per Share | (2.92) X | |||
| Total Asset | 2.92 M | |||
| Retained Earnings | (396.54 M) | |||
| Current Asset | 12.24 M | |||
| Current Liabilities | 4.85 M | |||
About Titan Pharmaceuticals Performance
Assessing Titan Pharmaceuticals' fundamental ratios provides investors with valuable insights into Titan Pharmaceuticals' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Titan Pharmaceuticals is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. The company was incorporated in 1992 and is based in South San Francisco, California. Titan Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 11 people.Things to note about Titan Pharmaceuticals performance evaluation
Checking the ongoing alerts about Titan Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Titan Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Titan Pharmaceuticals is not yet fully synchronised with the market data | |
| Titan Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (4.71 M) with loss before overhead, payroll, taxes, and interest of (4.37 M). | |
| Titan Pharmaceuticals currently holds about 6.42 M in cash with (3.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44. |
- Analyzing Titan Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Titan Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Titan Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Titan Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Titan Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Titan Pharmaceuticals' stock. These opinions can provide insight into Titan Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Titan Stock
If you are still planning to invest in Titan Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Titan Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |